Patent Oppositions in digestive drugs industry

Explore the competitive field of digestive drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in digestive drugs technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the digestive drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the digestive drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Oct 1, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Methods Of Treating Fabry DiseaseAMICUS THERAPEUTICSSep 24, 2026MAIWALD PATENTANWALTS
Methods Of Treating Crohn'S Disease With Anti-Il23 Specific AntibodyJANSSEN BIOTECHSep 14, 2026SIMMONS & SIMMONS
Formulation For Anti-Alpha4Beta7 AntibodyMILLENNIUM PHARMACEUTICALSSep 10, 2026CAMULON
Methods Of Treating Fabry Patients Having Renal ImpairmentAMICUS THERAPEUTICSSep 9, 2026MAIWALD PATENTANWALTS
Formulation For Anti-Alpha4Beta7 AntibodyMILLENNIUM PHARMACEUTICALSSep 9, 2026LEPTHIEN
Methods Of Treating Fabry Patients Having Renal ImpairmentAMICUS THERAPEUTICSSep 8, 2026TEVA PHARMACEUTICAL INDUSTRIES LTD
Methods Of Treating Fabry Patients Having Renal ImpairmentAMICUS THERAPEUTICSSep 8, 2026MAIWALD PATENTANWALTS
Formulation For Anti-Alpha4Beta7 AntibodyMILLENNIUM PHARMACEUTICALSSep 4, 2026ABEL & IMRAY
Method And Compositions For Inducing Differentiation Of Myeloid Derived Suppressor Cell To Treat Cancer And Infectious DiseasesOSE IMMUNOTHERAPEUTICSSep 3, 2026STRAWMAN
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMSep 2, 2026BARDEHLE PAGENBERG

To stay ahead in the competitive digestive drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the digestive drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Oct 1, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Apr 14, 2021Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGY22
Jan 21, 2015Bisphosphonic Acids For The Treatment And Prevention Of OsteoporosisATNAHS PHARMA UK12
Jan 7, 2026Formulations Of EnzalutamideMEDIVATION PROSTATE THERAPEUTICS11
Dec 11, 2019Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor AgonistNOVARTIS11
Jan 18, 2017Methods Of Administering Anti-Tnfalpha AntibodiesABBVIE BIOTECHNOLOGY11
Dec 11, 2019Methods Of Treating Hepatic EncephalopathySALIX PHARMACEUTICALS9
Oct 22, 2014Method For Treating Joint DamageBIOGEN IDEC9
Nov 14, 2018Therapeutic Uses Of EmpagliflozinBOEHRINGER INGELHEIM9
May 22, 2019Pharmaceutical Formulations Comprising 4-{(1R)-2- [(6-{2-[(2,6-Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2- (Hydroxymethyl)PhenolGLAXO GROUP8
Mar 3, 2021Tofacitinib Oral Sustained Release Dosage FormsPFIZER7